Investing in Public Cannabis Companies: Page 4

Corporate Cannabis Q2: Revenue Growth Steady, Profits Still Out of Reach

Big questions remain about corporate cannabis performance for the balance of 2020, with physical retail sales likely to be impacted until 2021—possibly beyond.

SPACs Are Changing the Cannabis Market M&A Landscape

But first: What exactly is a SPAC?

How We Got Here: The Financial Evolution of Commercial Cannabis

This special three-part series reflects on legislative, financial and regulatory developments that have altered state-legal cannabis programs during the past decade. Part II looks at how capital and investors shaped today’s market, and what that trajectory might mean for the industry’s future.

East Fork Cultivars Partners With Steward

The Oregon hemp and cannabis farm launched a fundraising campaign on the new crowd-funding site designed exclusively for farmers.

Cheetahs vs. Gazelles

In business, as in life, there are predators and there are prey. What does this dynamic mean for the cannabis industry?

Constellation Brands Exercises Warrants to Acquire Shares in Canopy Growth

The company says the move reinforces its confidence in Canopy's ability to win long-term in the emerging cannabis industry.

Cannabis and COVID-19: How the Pandemic Will Influence the Future of the Cannabis Industry

COVID-19 has affected every person and every business in the U.S. in some small or tragically large way.

How COVID-19 Is Impacting Public Cannabis Companies

New Cannabis Ventures’ Alan Brochstein offers a breakdown of near-term impacts and opportunities, as well as a longer-term industry analysis.

Did Market Saturation and Overspending Cause 2019 Cannabis Market Slump?

Expect the industry to rebound as companies refocus on customer value and experience over production capacity, says industry expert.

Navigating Merger Fervor and Other Deal-Making Tips: Q&A with Claudio Miranda, Part I

The Guild Enterprises co-founder explains changes occurring in the cannabis industry and what cultivators and dispensaries should consider when making changes to their company structures.

Aphria Inc. Enters Into Agreement to Receive $100 Million Strategic Investment from Institutional Investor

The funding strengthens Aphria's cash balance pro forma to nearly $600 million.

Toronto-Based FSD Pharma Begins Trading on NASDAQ

The stock begins trading under the symbol ‘HUGE’ on Jan. 9, placing FSD Pharma in a select group of 12 Canadian-domiciled cannabis companies trading on the NYSE or NASDAQ.

Previous Page

Page 4 of 5

Next Page